| Gene symbol | CD19 | Synonyms | B4, CVID3 | Type of gene | protein-coding |
| Chromosome | 16 | Map location | 16p11.2 | dbXrefs | |
| Description | CD19 molecule | ||||
| GTO ID | GTC2410 |
| Trial ID | NCT04488354 |
| Disease | Chronic Lymphocytic Leukemia | Small Lymphocytic Lymphoma | Burkitt Lymphoma | Marginal Zone Lymphoma | Waldenstrom Macroglobulinemia | Lymphoplasmacytic Lymphoma | Diffuse Large B-Cell Lymphoma | Primary Mediastinal B-Cell Lymphoma | Follicular Lymphoma | Mantle Cell Lymphoma |
| Altered gene | CD19 |
| Therapeutic/Target gene | Target gene |
| Therapy | CAR-T cell |
| Treatment | CLBR001 |
| Co-treatment | SWI019 |
| Phase | Phase1 |
| Recruitment status | Recruiting |
| Title | Long-term Follow-up Study for Patients Treated With CLBR001 CAR-T |
| Year | 2020 |
| Country | United States |
| Company sponsor | Calibr, a division of Scripps Research |
| Other ID(s) | CBR-sCAR19-3002 |
| Vector information | |||
|
|||
| Cohort 1 | |||||||||
|
|||||||||